-
Of Chloroquine and COVID-19: Evidence and Limits
2026-09-17
Touret and de Lamballerie’s commentary places early enthusiasm for Chloroquine against the broader antiviral literature, showing that cell-culture activity has repeatedly failed to predict reliable clinical benefit. Its main practical contribution is a tiered interpretation of evidence that distinguishes antiviral effects from immune modulation, disease-model dependence, and toxicity.
-
Dextran sulfate sodium salt (MW 35000-45000) Guide
2026-09-17
Build a reproducible DSS colitis workflow that separates epithelial injury from mucosal repair. This guide connects controlled chemical induction with GPR35–KLF5 pathway readouts for ulcerative colitis research, therapeutic testing, and mechanistic intestinal inflammation studies.
-
HyperTrap Heparin HP Column for Protein Workflows
2026-09-16
The HyperTrap Heparin HP Column combines a preloaded format with fine-particle HyperChrom Heparin HP Agarose for reproducible affinity purification of heparin-binding proteins. Its ready-to-use design supports syringe, pump, and chromatography-system workflows, making it useful for preparing defined protein inputs for signaling and cancer stem-cell assays.
-
OSMI-1 for Reproducible O-GlcNAc Assays
2026-09-15
A practical, scenario-based guide to using OSMI-1 (SKU B7923) in OGT inhibition, viability, and O-GlcNAcylation workflows. It explains dose interpretation, formulation, controls, safety limits, and vendor-selection criteria for more defensible cell-based results.
-
GVBE for Maternal Point Mutations in Pig Embryos
2026-09-15
The reference study introduces germinal vesicle oocyte base editing (GVBE), a strategy that edits maternal Dmd alleles during porcine oocyte maturation rather than after fertilization. Its embryo-level results show efficient formation of C>T-mutated alleles, while also revealing an important trade-off between editing and IVF blastocyst development.
-
Plant Nanovesicles Relieve Sertoli Cell Cycle Arrest
2026-09-14
This preprint identifies Cistanche deserticola-derived exosome-like nanovesicles (CDELNs) as a potential intervention for cyclophosphamide-induced testicular injury. Its central contribution is a mechanistic link between Sertoli-cell uptake mediated by heparan sulfate proteoglycans, delivery of miR159b-3p, suppression of P21, and restoration of CDK1-associated cell-cycle activity.
-
Cepharanthine for Reliable Apoptosis Assays
2026-09-14
This scenario-driven guide explains how Cepharanthine, SKU N2771, can support better-controlled viability, proliferation, and apoptosis workflows. It connects formulation, solvent control, organoid validation, mechanism-resolved readouts, and vendor-selection criteria to evidence from recent endometriosis models.
-
Cepharanthine Workflows for Apoptosis Research
2026-09-13
Build a translational Cepharanthine workflow that connects cell viability, patient-derived endometrial organoids, DNA-damage markers, and in vivo lesion analysis. This guide emphasizes model selection, formulation control, orthogonal apoptosis readouts, and practical troubleshooting rather than relying on a single endpoint.
-
SGC-CBP30 and the Hidden Logic of LUAD Super-Enhancers
2026-09-12
SGC-CBP30 offers a precise way to test whether CREBBP/EP300 bromodomain dependence helps sustain the LINC01977–TGF-β/SMAD3 program in lung adenocarcinoma. This thought-leadership analysis connects super-enhancer biology with experimental strategy while distinguishing established findings from translational hypotheses.
-
Koch-Like Validation of Xyleborus affinis Fungi
2026-09-12
A 2026 reference study combines improved mycangial isolation with host-colonisation assays to identify seven fungal associates of Xyleborus affinis, including four newly reported fungal partners. Its results show that ethanol-based recovery can underestimate fungal diversity and that detection is strengthened when fungal isolation is paired with functional colonisation evidence.
-
Cepharanthine Workflows for Endometriosis Research
2026-09-11
Build a translational Cepharanthine workflow that connects stromal-cell viability assays with patient-derived endometrial organoids and murine lesion models. Mechanism-resolved readouts for cell-cycle arrest, DNA damage, and apoptosis help distinguish disease-relevant activity from nonspecific solvent or culture effects.
-
SCH772984: Rethinking ERK1/2 Inhibition in Translation
2026-09-11
A translational framework for using SCH772984 to interrogate ERK signaling, mutant-driven tumor biology, and radioresistance while connecting MAPK output to the Ang II–HIF-1α–HILPDA axis in nasopharyngeal carcinoma.
-
AT13387: Hsp90 Inhibition Beyond Viability
2026-09-10
Explore how AT13387, a high-affinity Hsp90 inhibitor, can support mechanistic cancer biology research beyond simple viability assays. This article connects proteostasis disruption, apoptosis induction, and the NINJ1-dependent secretion findings reported in norovirus research while defining practical assay boundaries.
-
Ibotenic Acid for Circuit and Disease Models
2026-09-10
Ibotenic acid is a dual glutamate-receptor agonist for controlled excitotoxic perturbation, lesion-based circuit mapping, and neurodegenerative disease modeling. This guide connects product handling with the brain-to-spinal pain-circuit findings of Huo et al., while separating validated evidence from practical assay recommendations.
-
NSP2–MYB40 Control of Flavonoids and Symbiosis
2026-09-09
Gao and colleagues identify an NSP2–MYB40 regulatory module that connects nutrient-responsive flavonoid biosynthesis with rhizobial nodulation and arbuscular mycorrhizal colonization. The study combines genetic, transcriptional, promoter-binding, and protein-interaction evidence to explain how legumes tune symbiotic nutrient acquisition under changing conditions.